2,3-Dihydroxypropyl oleate

2,3-Dihydroxypropyl oleate is a lipid of Glycerolipids (GL) class. The involved functions are known as enzyme activity and acyltransferase activity. 2,3-dihydroxypropyl oleate often locates in soluble fraction.

Cross Reference

Introduction

To understand associated biological information of 2,3-Dihydroxypropyl oleate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with 2,3-Dihydroxypropyl oleate?

There are no associated biomedical information in the current reference collection.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 2,3-Dihydroxypropyl oleate

PubChem Associated disorders and diseases

What pathways are associated with 2,3-Dihydroxypropyl oleate

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with 2,3-Dihydroxypropyl oleate?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with 2,3-Dihydroxypropyl oleate?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with 2,3-Dihydroxypropyl oleate?

There are no associated biomedical information in the current reference collection.

What genes are associated with 2,3-Dihydroxypropyl oleate?

There are no associated biomedical information in the current reference collection.

What common seen animal models are associated with 2,3-Dihydroxypropyl oleate?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with 2,3-Dihydroxypropyl oleate

Download all related citations
Per page 10 20 50 100 | Total 520
Authors Title Published Journal PubMed Link
Almgren M et al. Dispersed lipid liquid crystalline phases stabilized by a hydrophobically modified cellulose. 2007 Langmuir pmid:17309220
Kraineva J et al. Effects of lipid confinement on insulin stability and amyloid formation. 2007 Langmuir pmid:17523690
Garg G et al. Cubosomes: an overview. 2007 Biol. Pharm. Bull. pmid:17268078
DeAngelis YM et al. Isolation and expression of a Malassezia globosa lipase gene, LIP1. 2007 J. Invest. Dermatol. pmid:17460728
Boyd BJ et al. A lipid-based liquid crystalline matrix that provides sustained release and enhanced oral bioavailability for a model poorly water soluble drug in rats. 2007 Int J Pharm pmid:17467935
Abe S and Takahashi H A comparative study of the effects of dimethylsulfoxide and glycerol on the bicontinuous cubic structure of hydrated monoolein and its phase behavior. 2007 Chem. Phys. Lipids pmid:17451662
Wadsten-Hindrichsen P et al. Aqueous self-assembly of phytantriol in ternary systems: effect of monoolein, distearoylphosphatidylglycerol and three water-miscible solvents. 2007 J Colloid Interface Sci pmid:17655855
Qin Z et al. Effect of membrane environment on proton permeation through gramicidin A channels. 2007 J Phys Chem B pmid:17672487
Woo JS et al. Formulation and biopharmaceutical evaluation of silymarin using SMEDDS. 2007 Arch. Pharm. Res. pmid:17328246
Lee WB et al. Anomalous phase sequences in lyotropic liquid crystals. 2007 Phys. Rev. Lett. pmid:17995439
Swarnakar NK et al. Enhanced oromucosal delivery of progesterone via hexosomes. 2007 Pharm. Res. pmid:17828445
Herai H et al. Doxorubicin skin penetration from monoolein-containing propylene glycol formulations. 2007 Int J Pharm pmid:17027205
Wörle G et al. Influence of composition and preparation parameters on the properties of aqueous monoolein dispersions. 2007 Int J Pharm pmid:16987623
Rosenblatt KM et al. Drug release from differently structured monoolein/poloxamer nanodispersions studied with differential pulse polarography and ultrafiltration at low pressure. 2007 J Pharm Sci pmid:17094136
Shearman GC et al. Calculations of and evidence for chain packing stress in inverse lyotropic bicontinuous cubic phases. 2007 Langmuir pmid:17503862
Issa JP et al. Bone repair in rat mandible by rhBMP-2 associated with two carriers. 2008 Micron pmid:17482469
Hinkula J et al. Safety and immunogenicity, after nasal application of HIV-1 DNA gagp37 plasmid vaccine in young mice. 2008 Vaccine pmid:18482783
Bender J et al. Lipid cubic phases in topical drug delivery: visualization of skin distribution using two-photon microscopy. 2008 J Control Release pmid:18538886
Yaghmur A et al. Calcium triggered L alpha-H2 phase transition monitored by combined rapid mixing and time-resolved synchrotron SAXS. 2008 PLoS ONE pmid:18446202
Ahmed AR et al. Reduction in burst release of PLGA microparticles by incorporation into cubic phase-forming systems. 2008 Eur J Pharm Biopharm pmid:18692569